Can unconscious persuasion in the form of a Slimpod programme help people with type 2 diabetes to lower blood sugar levels, cholesterol and blood pressure to recommended levels?

To test the efficacy of a Slimpod audio/visual intervention for type 2 diabetics with particular reference to achieving NICE recommended targets for management of HbA1C, blood pressure and cholesterol

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12612733

Enrollment

100

Registered

2020-09-08

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

Participants with a BMI over 25 and with a history of type 2 diabetes will be recruited by the GP practice staff for a 24-week trial. The planned size of the sample is circa 100. Simp

control group participants will receive the standard NICE guideline treatment which focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and ident

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Participants must have been registered as NHS patients at the Millgate Healthcare Partnership, 119 Manchester Road, Denton M34 3RA at least 4 weeks before the commencement of recruitment 2. Age between 30 and 65 3. BMI 25 or greater 4. Diagnosed as having type 2 diabetes 5. Any ethnicity 6. Any socio-economic grouping 7. Non gender-specific

Exclusion criteria

Exclusion criteria: 1. Outside of location stated above 2. Outside of stated age range 3. Not suffering from type 2 diabetes 4. Having a BMI <25

Design outcomes

Primary

Measure	Time frame
Measured by clinical staff at the GP practice at weeks 0, 12 and 24: 1. Blood pressure (systolic pressure and diastolic pressure) measured using a sphygmomanometer 2. Blood glucose levels measured using a glycated haemoglobin (HbA1c) test 3. Cholesterol and triglyceride fats measured using a lipid profile test 4. Weight measured in kilograms on the surgery’s scales	—

Secondary

Measure	Time frame
Prescribed doses of medication for controlling type 2 diabetes, reducing blood pressure and lowering cholesterol levels will be measured, recorded and then analysed using anonymised data from participants' medical notes at weeks 0, 12 and 24	—

Countries

United Kingdom

Contacts

Public ContactSandra Roycroft-Davis

sandra@thinkingslimmer.com+44 (0)7941131004

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026